Biotech can be a godsend for investors in a "stock picker's market"... Remember, today's market is a lot different than the market of the past 40 years.
This Is Exactly What We Want in a 'Stock Picker's Market'
By Marc Gerstein, director of research, Chaikin Analytics
Biotech can be a godsend for investors in a "stock picker's market"...
Remember, today's market is a lot different than the market of the past 40 years. As my colleague and Chaikin Analytics founder Marc Chaikin explained at the end of last month...
Stocks will [now] move up or down mainly based on company merit. If we misjudge anything, we can't count on the Federal Reserve's generosity to hand us good equity returns anyway.
In short, we're living in a stock picker's market.
I know what you might be thinking... At first, an industry focused so heavily on "growth" expectations like biotech doesn't seem like a smart approach in a volatile market.
But keep in mind...
This space is full of revolutionary breakthroughs. And as such, these companies' stocks will move up or down based on their own merit. The Fed won't have anything to do with it.
So in that way... it's exactly what we want.
I'll explain today how we can use the Power Gauge to dive deeper into the biotech space. And as you'll see, it's an area worth exploring as we face this new stock picker's market...
If you thought 2022's been tough in investors, just wait. Marc Chaikin says what's coming next will trigger huge gains AND huge losses by end of year. That's why this Thursday, September 22, Marc's going public with an urgent warning. He's calling it 'a financial lifeline' that could erase the last 8 months of stock market losses for those who act now - and trigger a wave of potential wealth so powerful, it could save your retirement.
A top analyst says NOBODY is safe from the crazy high energy bills he's forecasting in the weeks and months ahead. It doesn't matter where you live or how much money you have... if you're not ready to deal with what's coming, you could get absolutely blindsided. See his full warning here.
Our future depends on biotech. And these companies work on all sorts of progress...
Some biologics makers help fight previously untreatable conditions. Meanwhile, others focus on "human augmentation" – developing drugs that combat the effects of aging.
Personalized medicine is a huge game-changer, too...
Traditionally, drugmakers developed medications for broad populations. But now, thanks to technological advancements, they can focus their drugs on an individual's genetic makeup.
Right now, in this chaotic stock market, the Power Gauge tells us to look at biotech...
The Power Gauge currently rates 317 stocks in the industry as "bullish" or better. At the same time, 242 stocks rank "neutral" and only 37 have unfavorable grades today.
That's a lot of "bullish" from which to choose.
With all the volatility in the market right now, it's great to diversify your risk. So instead of focusing on specific companies, let's consider biotech exchange-traded funds ("ETFs")...
The biggest ETF in this industry is the iShares Biotechnology Fund (IBB). It has about $10 billion in assets under management ("AUM"). And today, its Power Gauge ranking is "very bullish."
Two tiny, niche ETFs also intrigued me as I looked closer at the biotech space. Both of them also rank "very bullish" right now...
The Virtus LifeSci Biotech Products Fund (BBP) has an AUM of only around $17 million. And the Virtus LifeSci Biotech Clinical Trials Fund (BBC) has an AUM of roughly $24 million.
On August 30, I explained that investors shouldn't fear extremely small ETFs...
These ETFs aren't like "penny stocks." They're tradable. And they tend to pursue interesting, non-generic strategies...
For example, BBP invests only in commercial "product stage" companies whose lead drug has already received U.S. Food and Drug Administration approval. And as its name implies, BBC invests specifically in companies whose lead drug is still undergoing trials.
The overall market has been awful this year. And it's on yet another downswing right now.
But in a stock picker's market, you can always find opportunities if you know where to look. The key is to focus on companies that don't need the Fed's help to succeed.
And as we learned today, the biotech space fits that bill.
Good investing,
Marc Gerstein
Editor's note: If you're looking for a guide during these turbulent times, you're in luck...
This Thursday night at 8 p.m. Eastern time, Marc Chaikin will join forces with one of the most brilliant investment minds he has ever met to host the 2022 Financial Lifeline Event.
During the event, attendees will learn about a "financial lifeline" that could essentially erase the past eight months of heartache, losses, and fear. But it's critical to listen carefully to this message... You could suffer even bigger losses if you're on the wrong side of the trade.
— According to the Chaikin Power Bar, Large Cap stocks are more Bearish than Small Cap stocks. Major indexes are mixed.
* * * *
Top Movers
Gainers
WRK
+5.48%
MOS
+5.12%
PKG
+5.11%
CF
+4.95%
IVZ
+4.79%
Losers
MRNA
-7.14%
MKTX
-5.38%
EW
-4.84%
AZO
-3.14%
DPZ
-2.91%
* * * *
Earnings Report
Reporting Today
Rating
Before Open
After Close
No earnings reporting today.
Earnings Surprises
AZO AutoZone, Inc.
Q4
$40.51
Beat by $1.89
* * * *
Sector Tracker
Sector movement over the last 5 days
Health Care
-3.89%
Staples
-3.95%
Financial
-4.04%
Utilities
-4.05%
Discretionary
-4.06%
Energy
-5.41%
Industrials
-6.12%
Communication
-6.40%
Materials
-6.48%
Information Technology
-7.14%
Real Estate
-8.04%
* * * *
Industry Focus
Capital Markets Services
11
40
13
Over the past 6 months, the Capital Markets subsector (KCE) has underperformed the S&P 500 by -1.39%. Its Power Bar ratio, which measures future potential, is Weak, with more Bearish than Bullish stocks. It is currently ranked #7 of 21 subsectors and has moved down 1 slot over the past week.
Indicative Stocks
COIN
Coinbase Global, Inc
MCO
Moody's Corporation
SPGI
S&P Global Inc.
* * * *
You have received this e-mail as part of your subscription to PowerFeed. If you no longer want to receive e-mails from PowerFeed, click here.
You're receiving this e-mail at diansastroxz.forex@blogger.com.
For questions about your account or to speak with customer service, call +1 (877) 697-6783 (U.S.), 9 a.m. - 5 p.m. Eastern time or e-mail info@chaikinanalytics.com. Please note: The law prohibits us from giving personalized investment advice.
Any brokers mentioned constitute a partial list of available brokers and is for your information only. Chaikin Analytics, LLC, does not recommend or endorse any brokers, dealers, or investment advisors.
Chaikin Analytics forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Chaikin Analytics, LLC (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation.
This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.
Post a Comment
Post a Comment